Clinical characterization of <em>ERBB2</em> exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients
Work
Year: 2018
Type: article
Abstract: ERBB2 exon 20 insertions (20ins) have been identified as oncogenic drivers in lung cancers. Lung cancer patients with 20ins benefit from afatinib. However, response heterogeneity was observed in patie... more
Source: OncoTargets and Therapy
Institutions Chinese PLA General Hospital, Hunan Cancer Hospital, Shandong Provincial Hospital, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University +5 more
Cites: 29
Cited by: 31
Related to: 10
FWCI: 3.005
Citation percentile (by year/subfield): 78.08
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,836